2014-03-15T10:24:15-05:00 2013-07-31 522041603 SQUIRE LEMKIN COMPANY LLP 111 ROCKVILLE PIKE SUITE 475 ROCKVILLE MD 20850 990 2012-08-01 452410498 RX-360 INTERNATIONAL PHARMACEUTICAL SUPPLY CHAIN CONSORTIUM RX-3 2022305142 1500 K STREET NW NO 1100 WASHINGTON DC 20005 MARTIN VANTRIESTE 2022305142 2014-03-13 1 JOHN SQUIRE P00308177 3014246800 2012 2015-11-30 17:44:51Z BRIAN JOHNSON 1500 K STREET NW NO 1100 WASHINGTON DC 20005 1755594 0 X WWW.RX-360.ORG X 2009 PA THE MISSION OF RX-360 IS TO PROTECT PATIENT SAFETY BY ENHANCING THE QUALITY OF THE SUPPLY CHAIN AND AUTHENTICITY OF MATERIALS WITHIN THE SUPPLY CHAIN. 18 18 0 0 0 0 0 0 1316749 1755594 0 0 0 0 1316749 1755594 0 0 0 0 0 0 0 0 0 1316749 1755594 1316749 1755594 0 0 411952 483272 411952 483272 0 0 TO CREATE AND MONITOR A GLOBAL QUALITY SYSTEM THAT MEETS THE EXPECTATIONS OF INDUSTRY AND REGULATORS, THAT ASSURES PATIENT SAFETY BY ENHANCING PRODUCT QUALITY AND AUTHENTICITY THROUGHOUT THE PHARMACEUTICAL SUPPLY CHAIN. 0 0 1755594 ENHANCING THE SECURITY OF THE PHARMACEUTICAL SUPPLY CHAIN THROUGH TWO AUDIT PROGRAMS AND RESEARCH PROGRAMS. THE RX-360 AUDIT SHARING PROGRAM ALLOWS RX-360 MEMBERS TO SHARE SUPPLIER QUALITY AUDITS CONDUCTED BY RX-360 MEMBERS OR ON THEIR BEHALF. THE RX-360 JOINT AUDITING PROGRAM ALLOWS RX-360 MEMBERS TO CONDUCT JOINT QUALITY AUDITS OF PHARMACEUTICAL SUPPLIES. RX-360 ALSO ANALYZES NEW LEGISLATION, REGULATIONS, STANDARDS, AND OTHER DEVELOPMENTS THAT IMPACT THE PHARMACEUTICAL SUPPLY CHAIN, AND MAKES THIS INFORMATION AVAILABLE TO RX-360 MEMBERS AND THE PUBLIC VIA RX-360'S WEBSITE. 1755594 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 X 18 18 0 1 0 0 1 1 1 1 0 0 0 1 1 1 1 0 0 0 0 0 X DRINKER BIDDLE & REATH LLP 2022305142 1500 K STREET NW NO 1100 WASHINGTON DC 20005 X BRIAN JOHNSON 3.00 X X 0 0 0 GUY VILLAX 3.00 X X 0 0 0 MARTIN VANTRIESTE 3.00 X X 0 0 0 TOM BEIL 2.00 X 0 0 0 JANICE BERMAN 2.00 X 0 0 0 THOMAS CRISPIN 2.00 X 0 0 0 DR HEIKE FALKENHAGEN 2.00 X 0 0 0 JOSEPH FAMULARE 2.00 X 0 0 0 HUBERTUS FOLTTMANN 2.00 X 0 0 0 JASPREET GILL 2.00 X 0 0 0 FRITHJOF HOLTZ 2.00 X 0 0 0 PATRICIA LATZO 2.00 X 0 0 0 LYNNE BYERS 812-413 2.00 X 0 0 0 JENNIFER MCCAFFERTY 413-713 2.00 X 0 0 0 MARK PAVIGLIANTI 2.00 X 0 0 0 ELIZABETH PILEGGI 2.00 X 0 0 0 WES SCHMIDT 2.00 X 0 0 0 MELISSA SEYMOUR 2.00 X 0 0 0 GORDON WHITTLE 2.00 X 0 0 0 0 0 0 0 0 0 0 DRINKER BIDDLE & REATH LLP 1500 K STREET NW SUITE 1100 WASHINGTON DC 20005 LEGAL 1174382 1 MEMBERSHIP DUES 900099 1755594 1755594 1755594 1755594 1755594 0 0 1174382 1174382 5180 5180 22654 22654 42657 42657 AUDIT FEES 510721 510721 1755594 1755594 0 0 411952 483272 411952 483272 264022 331689 147930 151583 411952 483272 X 0 0 0 0 0 0 0 0 411952 483272 0 0 X 0 0 0 0 1 0 EUROPE (INCLUDING ICELAND & GREENLAND) - 0 1 PROGRAM SERVICES - AUDITS QUALITY AUDITS OF PHARMACEUTICAL SUPPLIES. 95663 EAST ASIA AND THE PACIFIC - 0 1 PROGRAM SERVICES - AUDITS QUALITY AUDITS OF PHARMACEUTICAL SUPPLIES. 23890 MIDDLE EAST AND NORTH AFRICA 0 1 PROGRAM SERVICE AUDITS QUALITY AUDITS OF PHARMACEUTICAL SUPPLIES. 21084 NORTH AMERICA 0 1 PROGRAM SERVICE AUDITS QUALITY AUDITS OF PHARMACEUTICAL SUPPLIES. 10259 0 4 0 0 0 4 150896 0 150896 0 0 0 0 0 0 FORM 990, PART VI, SECTION A, LINE 3 DRINKER BIDDLE & REATH LLP (DBR) SERVES AS SECRETARIAT AND LEGAL COUNSEL TO RX-360. DAY TO DAY MANAGEMENT OF RX-360 IS PERFORMED BY DBR. FORM 990, PART VI, SECTION A, LINE 6 ANY LEGAL ENTITY MAY BECOME A MEMBER OF RX-360 IF THE FOLLOWING CRITERIA IS MET: 1. ITS ACTIVITIES RELATE TO THE RESEARCH, DEVELOPMENT, OR MANUFACTURE OF PHARMACEUTICAL OR BIOTECHNOLOGY PRODUCTS, INCLUDING RESEARCH-BASED PHARMACEUTICAL COMPANIES, GENERIC PHARMACEUTICAL COMPANIES, BIOTECHNOLOGY COMPANIES, AS WELL AS SUPPLIERS OF INGREDIENTS AND COMPONENTS OF PHARMACEUTICAL OR BIOTECHNOLOGY PRODUCTS AND SUPPLIERS OF SERVICES RELATING TO THE QUALITY OR SAFETY OF THE PHARMACEUTICAL OR BIOTECHNOLOGY SUPPLY. (PROVIDERS OF AUDITING AND CONSULTING SERVICES ARE NOT ELIGIBLE FOR RX-360 MEMBERSHIP). 2. IT AGREES TO PAY ANNUAL DUES AND ASSESSMENTS THAT ARE SET BY THE BOARD OF DIRECTORS. 3. IF IT IS A GOVERNMENTAL UNIT OR QUASI-GOVERNMENTAL UNIT OR AN EDUCATIONAL INSTITUTION, IT DOES NOT INVOLVE THE LEGISLATIVE, JUDICIAL OR EXECUTIVE BRANCHES OF GOVERNMENT AND ALL STEPS WILL BE TAKEN BY THE ENTITY TO RESIST OR RESTRICT ANY ATTEMPT MADE BY THE LEGISLATIVE, JUDICIAL OR EXECUTIVE BRANCHES TO OBTAIN ACCESS TO RX-360 REPORTS OR CONFIDENTIAL INFORMATION, AND APPROPRIATE MECHANISMS ARE IN PLACE AT THE ENTITY TO ENSURE CONFIDENTIALITY AND TO PREVENT IMPROPER DISCLOSURE. THERE ARE THREE CLASSES OF RX-360 MEMBERS, ONE CLASS FOR MANUFACTURERS OF PHARMACEUTICAL OR BIOTECHNOLOGY FINISHED PRODUCTS WITH $500 MILLION (US DOLLARS) OR MORE IN WORLDWIDE GROSS REVENUE FROM SALES OF PHARMACEUTICAL OR BIOTECHNOLOGY FINISHED PRODUCTS AMOUNG AFFILIATED ENTITIES, ONE CLASS FOR MANUFACTURERS OF PHARMACEUTICAL OR BIOTECHNOLOGY FINISHED PRODUCTS WITH LESS THAN $500 MILLION (US DOLLARS) IN WORLDWIDE GROSS REVENUE FROM SALES OF PHARMACEUTICAL OR BIOTECHNOLOGY FINISHED PRODUCTS AMOUNG AFFILIATED ENTITIES AND CONTRACT MANUFACTURERS OF FINISHED DOSAGE FORM PHARMACEUTICAL AND BIOTCHNOLOGY PRODUCTS AND ONE CLASS FOR SUPPLIERS OF INGREDIENTS AND COMPONENTS OF SUCH PRODUCTS AND SUPPLIERS OF SERVICES RELATING TO THE QUALITY OF SAFETY OF THE PHARMACEUTICAL OR BIOTECHNOLOGY SUPPLY CHAIN. FORM 990, PART VI, SECTION A, LINE 7A ALL MEMBERS HAVE EQUAL VOTING RIGHTS IN ELECTIONS OF OFFICERS. ALL MEMBERS ARE ELIGIBLE TO VOTE IN ELECTIONS OF THE BOARD OF DIRECTORS; HOWEVER, VOTING FOR BOARD MEMBERS IS DONE BY CATEGORY OF MEMBERSHIP. THE BYLAWS STATE THAT APPROXIMATELY 65% OF THE MEMBERSHIP OF THE BOARD SHALL BE COMPRISED OF REPRESENTATIVES OF LARGE FINISHED PRODUCT MANUFACTURERS ; APPROXIMATELY 10%OF THE MEMBERSHIP OF THE BOARD SHALL BE COMPRISED OF REPRESENTATIVES OF SMALL OR CONTRACT FINISHED PRODUCT MANUFACTURERS; AND APPROXIMATELY 25% SHALL BE COMPRISED OF REPRESENTATIVES OF SUPPLIERS. FORM 990, PART VI, SECTION A, LINE 7B THE BYLAWS OF RX-360 STATE THAT THE MEMBERS OF RX-360 HAVE THE POWER TO OVERRIDE ANY AMENDMENTS TO THE BYLAWS ADOPTED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 8B THERE IS CURRENTLY NO COMMITTEE WITH AUTHORITY TO ACT ON BEHALF OF THE BOARD, ALTHOUGH THE BYLAWS OF RX-360 ALLOW FOR THE CREATION OF SUCH COMMITTEES. FORM 990, PART VI, SECTION B, LINE 11 THE SECRETARIAT FIRST REVEIWS THE 990. ONCE THE SECRETARIAT IS SATISFIED THAT THE INFORMATION IS ACCURATE AND COMPLETE, IT IS FORWARDED TO THE CHAIR, VICE-CHAIR AND TREASURER FOR THEIR REVIEW. ONCE THEY ARE SATISFIED THAT THE INFORMATION IS ACCURATE AND COMPLETE, THE 990 IS FORWARED TO THE FULL BOARD PRIOR TO SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C A WRITTEN CONFLICT OF INTEREST POLICY WAS APPROVED BY THE BOARD IN MAY 2012. THE CONFLICT OF INTEREST POLICY IS CIRCULATED ANNUALLY TO OFFICERS, DIRECTORS AND BOARD MEMBERS. FORM 990, PART VI, SECTION C, LINE 19 RX-360'S BYLAWS AND ANTI-TRUST POLICY ARE AVAILABLE ON RX-360'S WEBSITE. ALL OTHER FINANCIAL DOCUMENTS THAT ARE REQUIRED TO BE MADE AVAILABLE TO THE PUBLIC WILL BE AVAILABLE THROUGH RX-360'S WEBSITE OR UPON REQUEST. RX-360 DOES NOT INTEND TO MAKE NON-REQUIRED DOCUMENTS AVAILABLE TO THE PUBLIC.